ArticleClinical chemistry2012
Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.
Article in Clinical chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- New York State's evidential oral fluid testing program.Journal of forensic sciences · 2026Article
- Detection of Cannabinoids in Oral Fluid Specimens as the Preferred Biological Matrix for a Point-of-Care Biosensor Diagnostic Device.Biosensors · 2024Review
- Stability of drugs of abuse in synthetic oral fluid investigated using a simple "dilute and inject" method of analysis.Drug testing and analysis · 2022Article
- Impact of QuantisalFrontiers in toxicology · 2021Article
- Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.Drug testing and analysis · 2017Article
- The effect of sodium fluoride, formaldehyde, and storage temperature on the stability of methamidophos in post-mortem blood and liver.International journal of legal medicine · 2017Article
- Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.Drug testing and analysis · 2017Article
- Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.Drug testing and analysis · 2016Article
- Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.Forensic science international · 2016Article
- Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.Drug testing and analysis · 2015Article
- Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.Drug testing and analysis · 2014Article
- The potential role of oral fluid in antidoping testing.Clinical chemistry · 2014Review
- Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.Analytical and bioanalytical chemistry · 2013Article
- Simultaneous quantification of Δ(9)-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry.Journal of chromatography. A · 2013Article
- Current knowledge on cannabinoids in oral fluid.Drug testing and analysisReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDefining cannabinoid stability in authentic oral fluid (OF) is critically important for result interpretation. There are few published OF stability data, and of those available, all employed fortified synthetic OF solutions or elution buffers; none included authentic OF following controlled cannabis smoking.
methodsAn expectorated OF pool and a pool of OF collected with Quantisal™ devices were prepared for each of 10 participants. Δ⁹-tetrahydrocannabinol (THC), 11-nor-9-carboxy-THC (THCCOOH), cannabidiol (CBD), and cannabinol (CBN) stability in each of 10 authentic expectorated and Quantisal-collected OF pools were determined after storage at 4 °C for 1 and 4 weeks and at -20 °C for 4 and 24 weeks. Results within ±20% of baseline concentrations analyzed within 24 h of collection were considered stable.
resultsAll Quantisal OF cannabinoid concentrations were stable for 1 week at 4 °C. After 4 weeks at 4 °C, as well as 4 and 24 weeks at -20 °C, THC was stable in 90%, 80%, and 80% and THCCOOH in 89%, 40%, and 50% of Quantisal samples, respectively. Cannabinoids in expectorated OF were less stable than in Quantisal samples when refrigerated or frozen. After 4 weeks at 4 and -20 °C, CBD and CBN were stable in 33%-100% of Quantisal and expectorated samples; by 24 weeks at -20 °C, CBD and CBN were stable in ≤ 44%.
conclusionsCannabinoid OF stability varied by analyte, collection method, and storage duration and temperature, and across participants. OF collection with a device containing an elution/stabilization buffer, sample storage at 4 °C, and analysis within 4 weeks is preferred to maximize result accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.